EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›TRS

TRS

TRIMAS CORP

Next earnings Jul 27, 2026 · consensus $0.50 EPS, $180M rev

Last earnings +2.6% on 2026-04-30

Hold
$44.58
▲ +1.16%
$44.58▲ +60.60%
over 1Y
L $27.48EODHDH $44.58
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.2%
1W+0.5%
1M+8.3%
3M+25.1%
YTD+23.1%
1Y+60.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B+
Valuation
Undervalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Buy

Healthy net margin (18.6%).

Revenue (FY2025) $646M · FY2025

The read

Middling fundamentals offset by an attractive price (~151% below fair value) — worth a look on the value angle.

TRIMAS CORP shows $646M in FY2025 revenue (+2.4% YoY), a 18.6% net margin, and 17.0% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$857M$884M$652M$631M$646M
Gross profit$217M$208M$153M$130M$138M
Operating income$95.1M$99.1M$50.7M$15.2M$41.3M
Net income$57.3M$66.2M$40.4M$24.3M$120M
Diluted EPS$1.32$1.56$0.97$0.60$2.95
Net margin6.7%7.5%6.2%3.8%18.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.12B
EV / EBITDA20.0
EV / Sales3.3
EV / FCF30.7
P / FCF24.3
PEG (trailing)0.04
Earnings yield7.2%
FCF yield4.1%

Quality & risk

ROIC (est.)2.8%
Free cash flow$69.1M
Total debt$473M
Net cash-$443M
Altman Z-Score2.16 grey
Piotroski F-Score5/9

Capital returns

Buyback yield6.2%
Dividend yield (est.)0.4%
Shareholder yield6.5%
Shares Δ YoY-7.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-05-21
  2. 8-K Earnings results2026-04-30
  3. 10-Q Quarterly report2026-04-30
  4. DEF 14A Proxy statement2026-03-31
  5. 8-K Acquisition / disposition2026-03-18
  6. 8-K Officer / director change2026-03-12
  7. 10-K Annual report2026-03-02
  8. 8-K Officer / director change2026-02-27
  9. 8-K Earnings results2026-02-26

Recent filings

all on EDGAR ↗
4Period ending 2026-06-242026-06-25open ↗SCHEDULE 13D/AFiling2026-06-08open ↗SDFiling2026-05-27open ↗8-KPeriod ending 2026-05-202026-05-21open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-052026-05-07open ↗144Filing2026-05-07open ↗144Filing2026-05-05open ↗10-QPeriod ending 2026-03-312026-04-30open ↗8-KPeriod ending 2026-04-302026-04-30open ↗4Period ending 2026-04-142026-04-16open ↗ARSPeriod ending 2025-12-312026-03-31open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueB
GrowthB+
ProfitabilityB
Financial healthB+
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$112.10

Undervalued +151% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.95 × (8.5 + 1.5 × 22.0% growth) × 1.05 quality = 38.0× multiple. An estimate, not a price target.

Revenue
$646M
+2.4% YoY
Net margin
18.6%
ROE
17.0%
P/E
15.1

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$646M+2.4%
Net income$120M+395.4%
Gross profit$138M+6.7%
Operating income$41.3M+172.2%
Diluted EPS$2.95+391.7%
Cash & equivalents$30.0M+30.1%
Total assets$1.49B+12.2%
Total liabilities$779M+18.7%
Stockholders' equity$706M+5.7%
Gross: 21.4%Op.: 6.4%L/E: 1.10x

Frequently asked

Is TRIMAS CORP (TRS) a buy?
TRS currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Healthy net margin (18.6%).
What is TRS's fair value?
A Modified-Graham model based on TRS's SEC fundamentals estimates a fair value of about $112.10. It is an estimate from reported earnings, not a price target.
Is TRS overvalued or undervalued?
Against a Modified-Graham fair-value estimate, TRS currently appears undervalued relative to its SEC-grounded earnings power.
What is TRIMAS CORP's quality score?
TRS scores 75.3529411764706/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000842633, latest 10-Q filed 2026-04-30) · EODHD · as of 6/26/2026, 6:50:45 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 2 sales

2026-06-24
Snyder Thomas James
President and CEO
Tax22.2K @ $43.60$966K
2026-05-13
Tredwell Daniel P
Director
Buy62.14 @ $40.58$2.52K
2026-05-07
Robin Jodi F.
General Counsel and Secretary
Sell2.00K @ $41.61$83.2K
2026-05-05
Robin Jodi F.
General Counsel and Secretary
Sell3.00K @ $41.10$123K
2026-04-14
SEDAGHAT SHAWN
Director
Award640.00 @ $39.03$25.0K
2026-03-20
Finley Teresa
Director
Tax6.19K @ $34.04$211K
2026-03-14
SEDAGHAT SHAWN
Director
Award2.85K
2026-03-14
Swart Paul
Chief Financial Officer
Award6.85K
2026-03-14
Robin Jodi F.
General Counsel and Secretary
Award5.42K
2026-03-14
Robin Jodi F.
General Counsel and Secretary
Tax2.39K @ $35.04$83.7K

Dividends

Quarterly
Yield (TTM)
0.4%
Annual / share
$0.16
Last ex-date
2026-05-07
Last amount
$0.04
ex 2026-05-07paid 2026-05-14$0.04
ex 2026-02-27paid 2026-03-06$0.04
ex 2025-11-06paid 2025-11-13$0.04
ex 2025-08-05paid 2025-08-12$0.04
ex 2025-05-06paid 2025-05-13$0.04
ex 2025-02-28paid 2025-03-07$0.04

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-30Beat +25.4% est▲ +2.61%8-K ↗
2026-02-26Beat +19900.0% est▲ +3.12%8-K ↗
2025-10-28Beat +7.2% est▼ -3.02%8-K ↗
2025-07-29Beat +25.6% est▲ +10.77%8-K ↗
2025-04-29—▲ +12.34%8-K ↗
2025-02-27—▼ -6.22%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2015-04-13Lamar SmithSell$1.00K–$15.0KPTR ↗
2015-04-13Lamar SmithSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
As U.S. profit margins near record highs, these small-cap stocks lead on profitabilityBullish
seekingalpha.com· 2026-06-18
Is IDEX (IEX) Stock Outpacing Its Industrial Products Peers This Year?Bullish
finance.yahoo.com· 2026-06-12
Gerresheimer Glass, Oliver, TriMas, Veritiv Visual announced closures in AprilBullish
finance.yahoo.com· 2026-05-05
Undervalued Small Caps With Insider Buying Opportunities In May 2026Bullish
finance.yahoo.com· 2026-05-01
TriMas Q1 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-05-01
Trimas outlines $1.50-$1.70 adjusted EPS guidance for 2026 following aerospace divestitureBullish
seekingalpha.com· 2026-04-30

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score75 vs 67
Revenue growth2.4% vs 7.1%
Net margin18.6% vs 10.5%
Return on equity17.0% vs 12.3%
P/E15.1 vs 25.5

News sentiment

EODHD · 5d
Bullish
+0.15
vs typical · 8 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.